News

This article from the NIH Fogarty Center highlights the research of Duke Psychiatry's Lauren Franz, MBBCh, MPH, focusing on her work developing interventions for subgroups within the autism spectrum. It also covers the value of partnerships and Dr. Franz's role as the director of the Duke Center for Autism and Brain Development.

For more than three decades, Duke Psychiatry's David Goldston, PhD, has studied suicide risk and prevention. His work spans suicide risk assessment, brief interventions, substance use, technology-based approaches, and the implementation of suicide prevention strategies across different settings. In honor of Suicide Prevention Month, he spoke about what drew him to suicide prevention research, the Center’s work, emerging approaches in the field, and why creating opportunities to talk openly about suicide remains so important.

In this Working@Duke article highlighting Duke staff and faculty who demonstrate encouragement, compassion, authenticity, and joy at work, Duke Psychiatry's Angela Tunno, PhD, shares her expertise on why that kind of steady positivity matters.

What does it mean to follow a physician's recommendations when healthy food is unaffordable, transportation is unreliable, or essential resources are out of reach?

Duke Psychiatry's Rebecca Shelby, PhD, and Tamara Somers, PhD, will lead the clinical coordinating center for a $13 million, five-year study funded by the Patient-Centered Outcomes Research Institute (PCORI). The study will aim to improve symptom management and quality of life for adults living with rare cholestatic liver diseases.

A study led by Duke Psychiatry's Joseph McClernon, PhD, found that more than 80% of smoking-cessation trials did not report whether participants continued smoking while vaping, raising questions about whether e-cigarettes truly help people quit.

Duke psychologist Bryan Sexton, PhD, shares simple, research-backed practices that can improve well-being, reduce burnout, and fit into even the busiest schedules.

A new $100,000 grant from the Sozosei Foundation will support the Wilson Center for Science and Justice at Duke Law in expanding access to Psychiatric Advance Directives, an area of expertise for Marvin Swartz, MD, professor of psychiatry and behavioral sciences and lead of the Wilson Center's Behavioral Health Team.

On a sweltering day in July, 15 young adults stayed cool as they gathered in a meeting space in Trinity House, a dorm on Duke’s East Campus, to talk about how to best use their often-limited energy

Duke Health researchers including Duke Psychiatry's P. Murali Doraiswamy, MBBS, studied more than 230 patients treated with lecanemab, a new FDA-approved therapy designed to remove a protein linked to Alzheimer’s disease from the brain. They found the therapy’s real-world safety, treatment persistence, and effects on disease progression aligned with results from clinical trials.